Home › Funds › Peloton Wealth Strategists › NBIX

Peloton Wealth Strategists position in NBIX

NEUROCRINE BIOSCIENCES INC · Health Care

Peloton Wealth Strategists reported holding 20,770 shares of NBIX (NEUROCRINE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$2.9M, representing 1.08% of its reported portfolio and ranking #39 among its reported holdings. Peloton Wealth Strategists has disclosed NBIX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)20.77K sh
Reported value held$2.95M
Portfolio Weight1.08%
First reportedQ3 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Peloton Wealth Strategists's NBIX position evolved

Peloton Wealth Strategists first disclosed a stake in NBIX in Q3 2024 at 3,515 shares (US$405K). The position peaked in Q3 2026 at 20,770 shares, worth US$2.9M. Across 9 filings, Peloton Wealth Strategists increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 20,770 shares valued at US$2.9M — an increase of 6,285 shares quarter over quarter.. Notable position changes include a 302% increase in Q4 2024 (shares fell 19% over the following quarter), a 43% increase in Q3 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 3.52K $405.00K New
Q4 2024 14.12K $1.93M Add
Q1 2025 14.99K $1.66M Add
Q2 2025 14.91K $1.87M Reduce
Q3 2025 13.81K $1.94M Reduce
Q4 2025 13.56K $1.92M Reduce
Q1 2026 13.34K $1.76M Reduce
Q2 2026 14.48K $2.44M Add
Q3 2026 20.77K $2.95M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NBIX and 13F data

NBIX (NEUROCRINE BIOSCIENCES INC) is a Health Care company. 30 other funds we track also report a position in NBIX — the largest reported positions include Two Sigma Investments (US$349.9M), Renaissance Technologies (US$326.3M), Vestal Point Capital, LP (US$316.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NBIX

All NBIX fund holders →

FAQ

How long has Peloton Wealth Strategists held NBIX?

Peloton Wealth Strategists has disclosed NBIX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Peloton Wealth Strategists's current position in NBIX?

As of Q3 2026, Peloton Wealth Strategists holds 20.77K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $2.95M, representing 1.08% of its reported portfolio and ranking #39.

Has Peloton Wealth Strategists been buying or selling NBIX?

In the latest 13F filing (Q3 2026), Peloton Wealth Strategists increased its position in NBIX. The position peaked in Q3 2026 at 20.77K shares.

Which other funds hold NBIX?

Other major institutional holders of NBIX include Two Sigma Investments, Renaissance Technologies, Vestal Point Capital, LP, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.